Inflammatory Bowel Disease (IBD) causes chronic inflammation (pain and swelling) in the intestines, called Crohn’s or Ulcerative Colitis. 2% of people have some form of IBD. The condition affects all ages, genders, and young adults. Surgery is often needed to resect the gut.
Irritable Bowel Syndrome (IBS) is a syndrome, or group of symptoms affecting 12% of the population. IBS is a functional GI disease and affects how the bowels function and can be called a spastic colon. IBS doesn’t inflame or damage the intestines like IBD, so imaging scans won’t detect it. People with IBS rarely need hospitalization or surgery.
This program is designed to quickly and easily educate about how and why cannabinoids can be helpful for alleviating the symptoms of various Autoimmune conditions.
Autoimmune conditions affect up to 10% of the population and include Rheumatoid Arthritis, Lupus, Type 1 Diabetes, Psoriasis, and Inflammatory Bowel Disease. This pathway program is designed to quickly teach you how and why cannabinoids can be helpful for alleviating the symptoms of various Autoimmune conditions.
This program includes:v
Inflammation is the culprit and research confirms that CBD reduces cytokines, IFN-gamma, and TNF-alpha treating the disease. Inhalation of THC reduces gastric motility, slowing down BMs, soothing pain, stimulating appetite, and improving quality of life. CBD may speed up gut motility helping those with constipation from IBS-C and decreasing anxiety over the condition.